Thyrocare Technologies Ltd THYROCARE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹534.15
- Day Range
- ₹519.30–538.55
- 52-Week Range
- ₹342.55–662.00
- Bid/Ask
- ₹531.20 / ₹533.60
- Shares Outstanding
- 159.16M
- Market Cap
- ₹84.93B
- Volume/Avg
- 223,853 / 710,729
Key Statistics
- Price/Earnings (Normalized)
- 43.53
- Price/Sales
- 9.72
- Dividend Yield (Trailing)
- 1.75%
- Dividend Yield (Forward)
- 1.75%
- Dividend Payment Schedule
- Jul, Oct
- Total Yield
- 1.75%
Company Profile
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others: Sale of testing equipment and consumables. The Diagnostic Testing Services segment provides Diagnostic and testing services, selling of consumables used for the collection and promotion of the pathology segment. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates Diagnostic and imaging services, selling of radio-pharmaceuticals, and selling of consumables for reporting. The Other business segment is engaged in the selling of glucometers and glucostrips under the brand name Sugarscan. The company earns the vast majority of its revenue in India.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,906
- Website
- https://www.thyrocare.com
Valuation
|
Metric
|
THYROCARE
|
|---|---|
Price/Earnings (Normalized) | 43.53 |
Price/Book Value | 14.67 |
Price/Sales | 9.72 |
Price/Cash Flow | 38.91 |
Price/Earnings
THYROCARE
Financial Strength
|
Metric
|
THYROCARE
|
|---|---|
Quick Ratio | 2.85 |
Current Ratio | 3.39 |
Interest Coverage | 69.45 |
Quick Ratio
THYROCARE
Profitability
|
Metric
|
THYROCARE
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
THYROCARE
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|y&?>^Mzb | LOCK|L?% | $242B | |||
| Danaher Corp
DHR
| LOCK|k%@xSwP< | LOCK|H?# | $150B | |||
| Agilent Technologies Inc
A
| LOCK|%D^GT$^ | LOCK|wt^ | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|S?>V>T | LOCK|!<lxj | $43B | |||
| Waters Corp
WAT
| LOCK|vyc#b> | LOCK|qQ | $42B | |||
| Illumina Inc
ILMN
| LOCK|JV@#!h | LOCK|HFzK$ | $41B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|@z?cX^xX | LOCK|MR! | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|!?lBM#Kd | LOCK|Y^#? | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|&pbBg> | LOCK|P?p?@ | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|%%lF#>X | LOCK|@RYy | $25B |
United States